Literature DB >> 7997474

Biotransformation of the naturally occurring lignan (-)-arctigenin in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.

R Kasper1, D Gansser, J Doehmer.   

Abstract

V79 Chinese hamster cells genetically engineered for stable expression of single forms of rat cytochromes P450 1A1, P450 1A2, and P450 2B1, and human P450 1A2 were used to analyse the metabolism of (-)-arctigenin. Concentrations of metabolites formed in the medium were determined by TLC, HPLC, GC, and GC-MS. Only in the cell line expressing rat P450 2B1 was (-)-arctigenin metabolized to a significant extent. The lignan was converted by O-demethylation to (-)-3'-O-demethylarctigenin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997474     DOI: 10.1055/s-2006-959528

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

1.  Elucidation of arctigenin pharmacokinetics after intravenous and oral administrations in rats: integration of in vitro and in vivo findings via semi-mechanistic pharmacokinetic modeling.

Authors:  Qiong Gao; Yufeng Zhang; Siukwan Wo; Zhong Zuo
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

Review 2.  Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L.

Authors:  Qiong Gao; Mengbi Yang; Zhong Zuo
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.